Supreme Court to decide Texas execution drug case

Bs_logoImage
AP Texas(US)
Last Updated : Apr 04 2014 | 1:46 AM IST
Attorneys for a serial killer asked the US Supreme Court to halt his execution set for today in Texas as they challenge that state's refusal to release information about where it gets its lethal injection drug.
Lawyers for Tommy Lynn Sells made the plea after a federal appeals court allowed the execution to stay on schedule. A lower court had stayed the execution yesterday, ordering Texas to reveal more information about its drug supplier, but the ruling was quickly tossed on appeal.
Sells, who was sentenced to death for fatally stabbing a 13-year-old South Texas girl in 1999, claims to have committed as many as 70 killings across the US The 49-year-old is scheduled to be lethally injected today evening in Huntsville.
Questions about the source of execution drugs have arisen in several US states in recent months as numerous drugmakers particularly in Europe, where opposition to capital punishment is strongest have refused to sell their products if they will be used in executions.
That's led several state prison systems to compounding pharmacies, which are not as heavily regulated by the US Food and Drug Administration as more conventional pharmacies.
Sells' attorneys argue that they need to know the name of the company now providing the state with pentobarbital, the drug used during executions, in order to verify the drug's quality and protect Sells from unconstitutional pain and suffering.
But 5th US Circuit Court of Appeals sided with Texas prison officials, who argued that information about the drug supplier must be kept secret to protect the company from threats of violence. It also found that the stock of the pentobarbital, a powerful sedative, falls within the acceptable ranges of potency.
The court said that had Texas wanted to use a drug never used before for executions or a completely new drug whose efficiency or science was unknown, "the case might be different."
It's unclear how the Supreme Court would rule. Last month it rejected similar arguments from a Missouri inmate's attorneys who challenged the secrecy surrounding where that state obtained its execution drugs, and the condemned prisoner was put to death.
Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Access to Exclusive Premium Stories Online

  • Over 30 behind the paywall stories daily, handpicked by our editors for subscribers

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Apr 04 2014 | 1:46 AM IST